Sarnova, Inc.

Based in the US, Sarnova, Inc. provides essential medical and healthcare products and services, focusing on emergency medical services and hospital markets to enhance patient care and operational efficiency. Sarnova, Inc. specializes in delivering medical products and services primarily to emergency medical services and hospital sectors.

Founded in 2008 in Dublin, US, the company underwent a significant transition in 2018 when Patricia Industries acquired an 86% majority stake for USD 900 mn from Talisman Capital Partners and Water Street Healthcare Partners. The acquisition aimed to bolster Sarnova's capabilities to serve its customers and fulfill its healthcare mission. The company was co-founded by Matthew Walter, and the current CEO is Brian LaDuke, along with Jeff Prestel. The most recent deal was completed in April 2018, following the funding round dated March 2018.

Sarnova has conducted a total of 2 deals since its inception. Sarnova specializes in providing a diverse range of medical and healthcare-related products and services, focusing primarily on emergency medical services (EMS) and hospital markets. Their core offerings include advanced medical equipment, essential supplies, and educational resources designed to enhance patient care and operational efficiency. These products address critical challenges faced by healthcare providers, such as improving response times in emergency situations and ensuring the availability of high-quality medical supplies.

Sarnova's customer base includes hospitals, EMS agencies, and healthcare professionals across various geographical markets in North America and specific international regions with established distribution networks. Sarnova generated revenue of USD 555,000,000 in the year 2017. The company operates a structured model that emphasizes B2B transactions, primarily targeting hospitals and EMS services as key clients. This includes direct sales of medical equipment and supplies complemented by service contracts for ongoing support and maintenance.

Sarnova is recognized for its flagship product lines, including life-saving medical devices and comprehensive training programs for healthcare professionals, ensuring a steady revenue stream from its diverse product offerings. Following the acquisition in April 2018, Sarnova aims to enhance its growth trajectory by focusing on the development of upcoming products designed for advanced emergency care and hospital applications. The company is targeting expansion into new geographic markets, particularly in Europe and Asia, over the next few years, leveraging its established distribution networks. The recent funding from Patricia Industries will support these initiatives, enabling Sarnova to achieve its growth targets and strengthen its operational capacity to improve patient care and service delivery.